-
EASL 2024 Chairman Interview: Breakthroughs and Challenges in Hepatology
From June 5-8, 2024, the European Association for the Study of the Liver (EASL) Annual Meeting was held in the cultural city of Milan, Italy. This premier academic event attracted over 7,000 hepatology professionals from around the world. During the conference, we had the privilege of interviewing the Chairman of this year’s conference, and current…
-
JOH | Inhibiting OXCT1 Activity in Tumor-Associated Macrophages Offers New Strategy for Hepatocellular Carcinoma Treatment
Hepatocellular carcinoma (HCC) is a common and highly lethal malignancy, with its treatment methods continuously evolving. In recent years, immunotherapy has become a hotspot in liver cancer treatment. Recently, Professor Zhexiong Lian’s team from Southern Medical University published a paper in the Journal of Hepatology, revealing the potential value of inhibiting OXCT1 activity in tumor-associated…
-
Professor Xinan Sheng: Latest Data from the LITESPARK-010 Study Explores Post-Line Treatment Strategies for Advanced Renal Cell Carcinoma in China
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was held from May 31 to June 4 in Chicago, USA, showcasing the latest advancements in urological oncology research. Among them, a phase I clinical study led by Professor Guo Jun from Peking University Cancer Hospital on belzutifan combined with lenvatinib for previously treated advanced…
-
Professor Anouk Hiensch: Exercise Effectively Alleviates Fatigue and Improves Quality of Life in Patients with Metastatic Breast Cancer (mBC)
Previous studies have extensively explored the impact of exercise on patients with early-stage cancer, but research on the effects of exercise in advanced cancer patients remains limited. The PREFERABLE-EFFECT study investigates how exercise influences the quality of life and fatigue in patients with metastatic breast cancer. Oncology Frontier invited Professor Anouk Hiensch, the principal investigator…
-
Professor Giuseppe Curigliano: Advances and Challenges in HR+ Breast Cancer Treatment
The 14th European Breast Cancer Conference (EBCC-14) was recently held in Milan, Italy, focusing on new clinical and translational research data in the multidisciplinary management of breast cancer. Oncology Frontier had the pleasure of interviewing the National Chair of this conference, Associate Professor Giuseppe Curigliano from the University of Milan, to discuss the highlights of…
-
ESMO BC 2024 | Professor Yiding Chen: Updated CAPItello-291 Study Data Pioneers Precision Therapy for the PAM Pathway in the Post-CDK4/6i Era
On May 16, 2024, the European Society for Medical Oncology Breast Cancer Annual Meeting (ESMO BC) reported updated results from the CAPItello-291 study (183MO). The data showed that the AKT inhibitor capivasertib combined with fulvestrant provided benefits in second-line treatment without affecting the benefits of subsequent treatments. This further solidified capivasertib’s role in the post-CDK4/6…
-
ASCO China Voice | Effect of Intensive vs. Standard Chemotherapy on High-Risk TNBC Patient Survival: A Study by Professors Zhimin Shao and Yizhou Jian
Triple-negative breast cancer (TNBC) is a highly heterogeneous subtype of breast cancer that is more aggressive and associated with a higher risk of early recurrence, metastasis, and death compared to other subtypes. The team led by Professors Zhimin Shao and Yizhou Jiang from the Breast Surgery Department at Fudan University Shanghai Cancer Center used a…
-
CDL (China Diabetes and Liver Disease Co-management Action Plan) Monthly Literature Review – May 2024, Issue 16
Diabetes and liver disease are common chronic diseases in China, with overlapping mechanisms, clinical manifestations, and therapeutic targets, making them interrelated risk factors. Co-managing these conditions can help reduce the disease burden. To support the development of diabetes and liver disease co-management in China, our publication, in collaboration with the China Diabetes and Liver Disease…
Connecting Medical Expertise through Media